Topic 4 - The Chemistry of Behavior PDF

Document Details

StrongerLlama

Uploaded by StrongerLlama

Tags

neurotransmitters neuropharmacology receptors biology

Summary

This document provides an overview of the chemistry of behavior, including receptor features, neurotransmitters, and basic pharmacology.

Full Transcript

Topic 4 The Chemistry of Behavior • Receptor Features • Neurotransmitters • Basic Pharmacology Types of receptors Ionotropic receptor – ligand-gated ion channel • Fast-acting changes in Vm Metabotropic receptors – (AKA G-protein coupled receptors (GPCRs)) activate intracellular signaling cascade...

Topic 4 The Chemistry of Behavior • Receptor Features • Neurotransmitters • Basic Pharmacology Types of receptors Ionotropic receptor – ligand-gated ion channel • Fast-acting changes in Vm Metabotropic receptors – (AKA G-protein coupled receptors (GPCRs)) activate intracellular signaling cascades • Slow but powerful and diverse effects • Multiple effects possible • Indirectly open ion channels • Change ion channel conductivity • Add/remove receptors • Alter gene expression • Signal amplification Types of receptors Opioid receptor mRNA distribution in human brain Receptor diversity A given neurotransmitter system can act on many receptor subtypes Raynor, Kong, Law, & Heerding, 1996 Major GABAA receptor subtypes Sinkkonen, 2004 Receptor subtypes can: • differ in anatomical distribution • work with different ions • respond to multiple NTs • interact within/across neuron populations to alter signaling in complex ways • have sub-subtypes (and sub-sub-subtypes) Neurotransmitters Neurotransmitter (NT) – endogenous chemical specialized for transmitting information between neurons • Endogenous – naturallyoccurring, originating from organism itself Neurotransmitter criteria Neurotransmitters: • are stored in axon terminals • are synthesized in neurons • are released when APs reach axon terminals • are recognized by receptors on the postsynaptic membrane. • evoke changes in a postsynaptic cell. Three (four?) major NT families Amino acids — GABA, glutamate, glycine, aspartate, histamine Amines — acetylcholine, dopamine, serotonin, norepinephrine, epinephrine, melatonin Neuropeptides — endorphins (class), dynorphins (class), enkephalins (class), oxytocin, vasopressin, neuropeptide Y, substance P, releasing hormones (class) Gases – nitric oxide, carbon monoxide  weird, break NT rules Amino acid – Glutamate Glutamate (Glu) - most common excitatory NT! Involved in every function • Key role in memory formation! Most Glu receptors are ionotropic and permeable to Na+ Important Glu receptors: • • • • AMPA NMDA kainate Metabotropic Glu receptors (mGluRs) – more on these in 301! Amino acid - GABA Gamma-aminobutyric acid (GABA) — most widely distributed inhibitory NT Controls excitability Classes of GABA receptors: -70 • GABAA receptors - ionotropic Clchannels • GABAB receptors – metabotropic, slow inhibition via K+ and other channels Amines Typically alter glutamateGABA signaling balance (neuromodulation) Amine transmitters are synthesized in one area, project throughout brain: • Acetylcholine • Monoamines • Catecholamines • Dopamine • Norepinephrine • Epinephrine • Indolamines • Serotonin • Melatonin Amines - Acetylcholine Acetylcholine (ACh) • Origin: basal forebrain • Learning/memory processes • NT used at neuromuscular junction (NMJ) • Released by parasympathetic nervous system • Major receptor families: • Nicotinic ACh receptor (nAChR) – mostly ionotropic (excitatory) • Muscarinic ACh receptor (mAChR) – metabotropic (excitatory or inhibitory) Amines – Catecholamines - Dopamine Dopamine (DA) is found in two major pathways: • Mesostriatal pathway — origin in substantia nigra • motor control • loss associated with Parkinson’s disease. • Mesolimbocortical pathway — origin in VTA • reward, reinforcement, and associative learning; • abnormalities associated with schizophrenia. Amines – Catecholamines - Dopamine Major receptor families (all metabotropic): • D1-like receptors: D1, D5 - excitatory • D2-like receptors: D2D4 – inhibitory Raza & Su, 2020 DA receptors often heteromerize with other GPCRs Amines – Catecholamines Norepinephrine Norepinephrine (NE) or noradrenaline (NA) Origins: • locus coeruleus (LC) • alertness, emotion, stress/anxiety, attention • lateral tegmental area (LTA) • sympathetic nervous system Amines – Catecholamines Norepinephrine Adrenergic receptors (or adenoceptors) – shared receptors for NE/NA and epinephrine/adrenaline (and other catecholamines Major receptor families (all metabotropic): • Alpha (α) receptors – α1, α2 • Beta (β) receptors – β1,β2,β3 Different receptors have differing affinities for NE versus epinephrine Amines – Indoleamines Serotonin Serotonin (5-HT) – 5hydroxytryptamine • Origins: raphe nuclei • Many functions: mood, anxiety, sexual behavior • Tons of receptors (all but one metabotropic) • 5-HT1, 5-HT2 … 5-HT14 Neuropeptides Chains of typically 10 amino acids or more • large molecules  expensive to synthesize • Typically synthesized on demand where/when needed • Dedicated, specific behavioral functions Opioid peptides - mimicked by opiate drugs • Endorphins, enkephalins – reward/pleasure, control of pain Pituitary hormones • oxytocin and vasopressin – reproductive behavior, socialization Peptides in gut, spinal cord, or brain • Neuropeptide Y - feeding Gases Classified as NTs despite usually breaking the rules: • Produced outside axon terminals (dendrites) • Do not require receptors • Often retrograde transmitters – travel from postsynaptic back to presynaptic neuron Pharmacology Pharmacology - study of how drug affect the body as a whole Neuropharmacology – study of drug effects specifically on the brain. Neuropharmacology terminology Ligand - a substance that binds to a receptor. Agonist - initiates normal effects of the transmitter on that receptor. Antagonist - binds to a receptor and does not activate it, prevents binding by other ligands. Inverse agonist - initiates the reverse of the normal effect. Neuropharmacology terminology Competitive – drug directly competes with endogenous ligand at binding site Noncompetitive – drug does not directly compete, binds to modulatory site instead Pharmacology Binding affinity - degree of chemical attraction between ligand and receptor. • High affinity drugs effective at very low doses. • NTs are low-affinity ligands - can rapidly dissociate from receptors. Pharmacology Efficacy - ability of a bound ligand to activate the receptor. • Agonists have high efficacy; antagonists have low efficacy. Partial agonists produce a medium response regardless of dose. Combination of affinity and efficacy determines the overall action of a drug. Measuring efficacy and affinity Dose-response curve (DRC) - graph of the relationship between drug doses and effects. Pharmacodynamics - the functional relationship between drugs and their targets. Comparing DRCs A) Effective Dose 50% (ED50) – dose that shows half of its maximal effect B) A is more potent than B (lower ED50) C) A has higher maximal response than B. B is a partial agonist D) Nonmonotonic DRC – as dose increases, drug starts to have effect elsewhere in system Bioavailability Amount of drug in body that is free to act Bioavailability varies with route of administration • • • • PO – peroral SC – subcutaneous IM – intramuscular IV - intravenous National Pain Centers More pharmacology! Pharmacokinetics - factors that affect movement of a drug through the body. Blood-brain barrier (BBB)—tight junctions around blood vessels in the CNS protects the brain from toxins/pathogens in blood Prevents many potentially therapeutic drugs from getting to the brain. Bypassing the BBB Nanoparticles - special molecules designed to get drugs past the BBB. • Often coated with molecules that trick the BBB into transporting it into brain • Nickname: Trojan horses Tolerance Reduced effectiveness of a drug after repeated treatments Two key forms: • Metabolic tolerance • Functional tolerance Metabolic tolerance Organ systems become more effective at eliminating drug • Less drug reaches site of action Example: alcohol Parker, Kim, & Gao, 2017 Functional tolerance The tissue targeted by drug alters its sensitivity by changing number of receptors present in the postsynaptic membrane • Down-regulate - fewer receptors available • Agonist drugs • Example – opioid drugs! • Up-regulate – more receptors available • Antagonist drugs Milligan et al., 2001 Cross-tolerance Tolerance to one drug is generalized to other drugs in its class • Drugs that work on same receptors will show cross-tolerance Example: Alcohol, benzodiazepines, barbiturates all act at GABAA receptors Your action items (9/12) Neuroanatomy test is this week in lab (9/12 and 9/14) Listen to Radiolab: The Fix and be ready to discuss • PRA2 due in lab next week Coming Up: • Thursday: Drugs and Addiction (Breedlove 4.4-4.7) Our next GBP talk!

Use Quizgecko on...
Browser
Browser